Celldex Therapeutics EV - Enterprise Value 2011-2026 | CLDX

Annual EV - Enterprise Value Celldex Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.07 B	1.33 B	2.33 B	-895 K	-12.6 M	-16.7 M	51.2 M	71.7 M	399 M	405 M	781 M	1.92 B	1.96 B	425 M	195 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.33 B	-16.7 M	794 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Biohaven Pharmaceutical Holding Company Ltd. BHVN	10.2 B	$ 9.32	1.19 %	$ 603 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	9.45 M	$ 0.89	0.51 %	$ 6.54 M	China
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	3.33 B	$ 22.48	1.26 %	$ 3.73 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Innoviva INVA	1.07 B	$ 23.09	0.17 %	$ 1.56 B	USA
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	-4.91 B	$ 104.34	2.72 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Innate Pharma S.A. IPHA	259 M	$ 1.45	-2.03 %	$ 235 M	France
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 2.95	-1.34 %	$ 4.86 M	Israel
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Aquestive Therapeutics AQST	540 M	$ 4.08	0.74 %	$ 436 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	38.2 M	-	17.91 %	$ 11.1 M	USA
Arcutis Biotherapeutics ARQT	3.64 B	$ 22.96	2.64 %	$ 2.92 B	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Edesa Biotech EDSA	6.91 M	$ 15.11	-4.97 %	$ 48.3 M	USA
Athira Pharma ATHA	-4.92 M	-	-	$ 269 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Avenue Therapeutics ATXI	-1.76 M	-	-52.27 %	$ 4.45 M	USA
Aileron Therapeutics ALRN	4.02 M	-	10.36 %	$ 9.8 M	USA
Autolus Therapeutics plc AUTL	629 M	$ 1.44	1.77 %	$ 383 M	Britain
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
Evogene Ltd. EVGN	-4.88 M	$ 0.76	-0.42 %	$ 27.9 M	Israel
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Exelixis EXEL	11.9 B	$ 45.14	1.01 %	$ 12.3 B	USA